# US 2005/0032121 A1 · Method of analyzing data obtained from a biological assay

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0032121 A1
- Document ID: US20050032121A1
- Status: Published application
- Kind: A1
- Application number: 10/898,920
- Filed: 2004-07-26
- Published: 2005-02-10
- Earliest claimed: 2003-08-04
- Assignees: Pierce Biotechnology, Inc.
- Inventors: S. King-Spengler
- Web page: https://patentgrep.com/patent/US20050032121A1

## CPC

- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B 35/20: Screening of libraries
- G16C 20/70: Machine learning, data mining or chemometrics
- G16B 35/00: ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
- G16C 20/50: Molecular design, e.g. of drugs
- G16C 20/60: In silico combinatorial chemistry
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE

## Abstract

A method of analyzing data obtained from a biological assay, which method comprises (a) performing a biological assay, which quantitates a biological activity, (b) obtaining data resulting from the biological assay, and (c) analyzing the data using a dimensionally homogeneous equation, whereupon the data obtained from the biological assay are analyzed.

## Claims

### Claim 1

A method of analyzing data obtained from a biological assay, which method comprises:
(a) performing a biological assay, which quantitates a biological activity,
(b) obtaining data resulting from the biological assay, and
(c) analyzing the data using a dimensionally homogeneous equation,
whereupon the data obtained from the biological assay are analyzed.

### Claim 2 (depends on 1)

The method of claim 1, wherein the biological activity quantitated by the biological assay is activity of one or more enzyme inhibitors.

### Claim 3 (depends on 2)

The method of claim 2, wherein the dimensionally homogeneous equation is Equation [1]:
ρ=1/(1+ψI−h) [1],
and the method identifies the enzyme inhibitor having the most biological activity and/or the enzyme inhibitor having the least biological activity.

### Claim 4 (depends on 2)

The method of claim 2, wherein the dimensionally homogeneous equation is Equation [2]:
ρ
i
=
1
1
+
(
EC
50
[
Inhibitor
]
)
h
,
[
2
]
and the method identifies the enzyme inhibitor having the most biological activity and/or the enzyme inhibitor having the least biological activity.

### Claim 5 (depends on 1)

The method of claim 1, wherein the biological activity quantitated by the biological assay is activity of one or more enzymes.

### Claim 6 (depends on 5)

The method of claim 5, wherein the dimensionally homogeneous equation is Equation [3]:
ρ
=
RFU
_
sample
-
RFU
_
MAX
RFU
_
o
-
RFU
_
MAX
,
[
3
]
and the method identifies the enzyme having the most activity and/or the enzyme having the least activity.

### Claim 7 (depends on 1)

The method of claim 1, wherein the biological activity quantitated by the biological assay is activity of one or more enzyme inducers.

### Claim 8 (depends on 7)

The method of claim 7, wherein the dimensionally homogeneous equation is Equation [1]:
ρ=1/(1+ψI−h) [1],
and the method identifies the enzyme inducer having the most biological activity and/or the enzyme inducer having the least biological activity.

### Claim 9 (depends on 7)

The method of claim 7, wherein the dimensionally homogeneous equation is Equation [2′]:
ρ
i
=
1
1
+
(
EC
50
[
Inducer
]
)
h
,
[
2
′
]
and the method identifies the enzyme inducer,having the most biological activity and/or the enzyme inducer having the least biological activity.

### Claim 10 (depends on 1)

The method of claim 1, wherein the biological activity quantitated by the biological assay is binding activity of a ligand to a target protein.

### Claim 11 (depends on 10)

The method of claim 10, wherein the dimensionally homogeneous equation is Equation [4]:
ρ
=
1
n
⁢
∑
i
=
1
n
⁢
⁢
1
1
+
K
D
,
i
C
,
[
4
]
and the method identifies the ligand having the most affinity for a target protein and/or the ligand having the least affinity for a target protein.

### Claim 12 (depends on 1)

The method of claim 1, wherein the biological activity quantitated by the biological assay is activity of one or more ligand inhibitors.

### Claim 13 (depends on 12)

The method of claim 12, wherein the dimensionally homogeneous equation is Equation [5]:
ρ
b
=
1
1
+
(
EC
50
[
Inhibitor
]
)
h
[
5
]
and the method identifies the ligand inhibitor having the most activity and/or the ligand inhibitor having the least activity.

### Claim 14 (depends on 1)

The method of claim 1, wherein the biological activity quantitated by the biological assay is activity of one or more ligand inducers.

### Claim 15 (depends on 14)

The method of claim 14, wherein the dimensionally homogeneous equation is Equation [5′]:
ρ
b
=
1
1
+
(
EC
50
[
Inducer
]
)
h
[
5
′
]
and the method identifies the ligand inducer having the most activity and/or the ligand inducer having the least activity.
